Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study.


Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
01 2020
Historique:
received: 21 01 2019
accepted: 15 04 2019
pubmed: 21 4 2019
medline: 28 4 2021
entrez: 21 4 2019
Statut: ppublish

Résumé

Acute myeloid leukemia (AML) with t(6;9)(p22;q34) is a distinct entity accounting for 1-2% of AML cases. A substantial proportion of these patients have a concomitant

Identifiants

pubmed: 31004014
pii: haematol.2018.208678
doi: 10.3324/haematol.2018.208678
pmc: PMC6939530
doi:

Substances chimiques

Cytarabine 04079A1RDZ

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

161-169

Subventions

Organisme : NCI NIH HHS
ID : K12 CA184746
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA100632
Pays : United States

Informations de copyright

Copyright© 2020 Ferrata Storti Foundation.

Références

Lancet Oncol. 2017 Aug;18(8):1061-1075
pubmed: 28645776
Leukemia. 2017 Jun;31(6):1306-1313
pubmed: 28138160
Mol Cell Biol. 1998 Mar;18(3):1236-47
pubmed: 9488438
Control Clin Trials. 1996 Aug;17(4):343-6
pubmed: 8889347
Mol Cell Biol. 1992 Apr;12(4):1687-97
pubmed: 1549122
Br J Haematol. 2012 Aug;158(4):519-22
pubmed: 22639959
J Clin Oncol. 2003 Dec 15;21(24):4642-9
pubmed: 14673054
J Natl Compr Canc Netw. 2017 Jul;15(7):926-957
pubmed: 28687581
Blood. 2015 Jun 18;125(25):3878-85
pubmed: 25833957
Oncogene. 2002 May 13;21(21):3422-44
pubmed: 12032780
Genes Chromosomes Cancer. 2008 Apr;47(4):276-87
pubmed: 18181180
Br J Haematol. 2009 Jun;145(5):598-605
pubmed: 19344426
J Clin Oncol. 2013 Jun 10;31(17):2094-102
pubmed: 23630210
Int J Lab Hematol. 2017 Aug;39(4):409-417
pubmed: 28318095
Leukemia. 2012 Mar;26(3):461-4
pubmed: 21869835
Ann Intern Med. 1985 Oct;103(4):620-5
pubmed: 3862359
Am J Clin Pathol. 2004 Sep;122(3):348-58
pubmed: 15362364
Cancer Genet Cytogenet. 2010 Dec;203(2):297-302
pubmed: 21156248
Leukemia. 2017 May;31(5):1217-1220
pubmed: 28096533
Leukemia. 2006 Jul;20(7):1295-7
pubmed: 16628187
J Clin Oncol. 2017 Apr 10;35(11):1223-1230
pubmed: 28221862
Blood. 2017 Mar 2;129(9):1143-1154
pubmed: 27872058
Br J Haematol. 2014 Jul;166(2):254-259
pubmed: 24661089
Stat Med. 1984 Jan-Mar;3(1):35-44
pubmed: 6729287
Blood. 1976 May;47(5):705-21
pubmed: 1260131
J Clin Oncol. 2011 Jul 1;29(19):2696-702
pubmed: 21606413
Arch Pathol Lab Med. 2008 Nov;132(11):1835-7
pubmed: 18976025
Blood. 2010 Jul 22;116(3):354-65
pubmed: 20385793
Blood. 2011 Aug 18;118(7):1754-62
pubmed: 21690555
J Clin Oncol. 2010 Feb 10;28(5):808-14
pubmed: 20048183
Haematologica. 2014 Oct;99(10):e185-7
pubmed: 24972769
Leuk Lymphoma. 2014 Feb;55(2):243-55
pubmed: 23631653
Blood. 2016 Mar 24;127(12):1551-8
pubmed: 26755712
Leukemia. 2010 Nov;24(11):1910-9
pubmed: 20827285
Leukemia. 1997 Oct;11(10):1605-9
pubmed: 9324277
J Clin Oncol. 2011 Jul 10;29(20):2758-65
pubmed: 21632498
J Clin Oncol. 2014 Jan 20;32(3):219-28
pubmed: 24297940
Haematologica. 2014 May;99(5):865-72
pubmed: 24441146
Blood. 2002 Jun 15;99(12):4326-35
pubmed: 12036858
N Engl J Med. 2017 Aug 3;377(5):454-464
pubmed: 28644114

Auteurs

Sabine Kayser (S)

Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg, Germany s.kayser@dkfz-heidelberg.de.
German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.

Robert K Hills (RK)

Cardiff University School of Medicine, Cardiff, UK.

Marlise R Luskin (MR)

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Andrew M Brunner (AM)

Massachusetts General Hospital, Boston, MA, USA.

Christine Terré (C)

Laboratory of Hematology, André Mignot Hospital, Le Chesnay, France.

Jörg Westermann (J)

Department of Hematology, Oncology and Tumor Immunology, Charité-University Medical Center, Campus Virchow Clinic, Berlin, Germany.

Kamal Menghrajani (K)

Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA.

Carole Shaw (C)

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Division of Hematology/Department of Medicine, University of Washington, Seattle, WA, USA.

Maria R Baer (MR)

University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.

Michelle A Elliott (MA)

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.

Alexander E Perl (AE)

Division of Hematology and Oncology, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.

Zdeněk Ráčil (Z)

Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.

Jiri Mayer (J)

Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.

Pavel Zak (P)

4 Department of Internal Medicine-Hematology, Faculty of Medicine, Charles University and University Hospital Hradec Králové, Hradec Králové, Czech Republic.

Tomas Szotkowski (T)

Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic.

Stéphane de Botton (S)

Université Paris-Saclay, Gustave Roussy Villejuif, France.

David Grimwade (D)

Department of Medical & Molecular Genetics, King's College London, Faculty of Life Sciences and Medicine, London, UK.

Karin Mayer (K)

Medical Clinic III for Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany.

Roland B Walter (RB)

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Division of Hematology/Department of Medicine, University of Washington, Seattle, WA, USA.
Department of Epidemiology, University of Washington, Seattle, WA, USA.

Alwin Krämer (A)

Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg, Germany.
German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.

Alan K Burnett (AK)

Cardiff University School of Medicine, Cardiff, UK.

Anthony D Ho (AD)

Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg, Germany.

Uwe Platzbecker (U)

Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany.

Christian Thiede (C)

Department of Internal Medicine I, University Hospital Carl-Gustav-Carus, Dresden, Germany.

Gerhard Ehninger (G)

Department of Internal Medicine I, University Hospital Carl-Gustav-Carus, Dresden, Germany.

Richard M Stone (RM)

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Christoph Röllig (C)

Department of Internal Medicine I, University Hospital Carl-Gustav-Carus, Dresden, Germany.

Martin S Tallman (MS)

Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA.

Elihu H Estey (EH)

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Division of Hematology/Department of Medicine, University of Washington, Seattle, WA, USA.

Carsten Müller-Tidow (C)

Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg, Germany.

Nigel H Russell (NH)

Department of Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.

Richard F Schlenk (RF)

NCT Trial Center, National Center for Tumor Diseases, Heidelberg, Germany.

Mark J Levis (MJ)

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH